Key result
Abnormal fetuses demonstrated significantly weaker fetus-to-mother heart rate coupling (0.08 vs 0.44) and stronger mother-to-fetus coupling (0.66 vs 0.46) compared to normal fetuses (p < 0.01).
Why the study?
It was unknown whether maternal-fetal heart rate coupling patterns and directions change in abnormal pregnancies compared with normal pregnancies.
Does maternal-fetal cardiac coupling strength and direction differ between normal and abnormal pregnancies?
Cross-Sectional (n=85)
No
Does maternal-fetal cardiac coupling strength and direction differ between normal and abnormal pregnancies?
Maternal-fetal cardiac coupling strength and direction, measured via NSTPDC, differ significantly between normal and abnormal pregnancies and could serve as novel clinical markers of prenatal development.
Weakening fetal-to-maternal cardiac coupling with gestation is hypothesis-generating; leaves open its utility for fetal monitoring.
Because fetal gas exchange occurs via the maternal placenta, there has been growing interests in understanding the patterns and directions of maternal-fetal cardiac coupling. We recently reported the evidence of short-term maternal–fetal cardiac couplings in normal fetuses by using Normalized Short Time Partial Directed Coherence (NSTPDC) technique. Our results have shown weakening of coupling from fetal heart rate to maternal heart rate as the fetal development progresses while the influence from maternal to fetal heart rate coupling behaves oppositely. The aim of this study was to test if maternal-fetal coupling patterns change in various types of abnormal cases of pregnancies. We applied NSTPDC on simultaneously recorded fetal and maternal beat-by-beat heart rates collected from fetal and maternal ECG signals of 66 normal and 19 abnormal pregnancies. NSTPDC fetal-to-maternal coupling analyses revealed significant differences between the normal and abnormal cases (normal: normalized factor (NF)=-0.32±0.71, fetus-to-mother coupling area (A_fBBI→mBBI) =0.43±0.12, mother-to-fetus coupling area (A_mBBI→fBBI)=0.50±0.12; abnormal: NF=-1.66±0.77, A_fBBI→mBBI=0.08±0.12, A_mBBI→fBBI=0.66±0.24; p<0.01). In conclusion, maternal-fetal cardiac coupling strength and direction and their associations with regulatory mechanisms (patterns) of developing autonomic nervous system function could be novel clinical markers of healthy prenatal development and its deviation. However, further research is required on larger samples of abnormal cases.
No takes yet. Share an insight, caveat, or question.
Khandoker et al. (2019) conducted a cross-sectional in Fetal abnormalities (n=85). Abnormal fetal conditions vs. Normal fetuses was evaluated on Fetus-to-mother coupling area (A_fBBI → mBBI) (p=<0.01). Abnormal fetuses demonstrated significantly weaker fetus-to-mother heart rate coupling (0.08 vs 0.44) and stronger mother-to-fetus coupling (0.66 vs 0.46) compared to normal fetuses (p < 0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: